Cyclosporine inhibits catabolism of low‐density lipoproteins in HepG2 cells by about 25%
O A Rayyes, A Wallmark, C Florén – 1 September 1996 – The aim of this study was to elucidate the possible causes of elevated low‐density lipoprotein (LDL)‐cholesterol levels in transplanted patients treated with the immunosuppressant drug, cyclosporine. HepG2 cells, from a well‐differentiated cell‐line of hepatoma cells, were cultured and used as a model for in vitro hepatocytic LDL uptake. Different concentrations of cyclosporine, which were within the range of concentrations found in humans treated with cyclosporine, were added to tissue culture medium together with 125I‐LDL.